五肽胃泌素及其类似物对大鼠胃粘膜细胞DNA合成的作用

 利用细胞培养的方法,测定五肽胃泌素(Boc-β-Ala-Trp-Met-Asp-phe·NH_2)、葡萄糖-1-脱氧果糖四肽(GIe-1-Deoxyflu-Trp-Met-Asp-phe·NH_2)及Boc-三肽(Boc-Met-Asp-Phe·NH_2)等胃泌素类似物对~3H-胸腺嘧啶核苷(~3H-TdR)参入胃粘膜细胞DNA合成的影响。实验结果表明五肽胃泌素对胃粘膜细胞DNA合成有明显促进作用,而泌酸活性比五肽胃泌素还强的葡萄糖-1-脱氧果糖四肽却没有这种作用。进一步证明胃泌素的营养作用是独立于泌酸活性而存在的,二者有着不同的作用机理。     

胃泌素类似物的人工合成和泌酸活性研究

本文采用液相合成法合成了九种胃泌素类似物,并用大白鼠胃灌流技术测定其泌酸活性。若以五肽胃泌素(Boc-β-Ala-Trp-Met-Asp-phe-NH_2,Boc-五肽)的泌酸活性为100％,则胃泌其它类似物的活性分别为:Boc-四肽(Boc-Trp-Met-Asp-Phe-NH_2)30.32％,Boc-三肽(Boc-Met-Asp-phe-NH_2)0.13％;Fmoc-五肽(Fmoc-β-Ala-Trp-Met-ASP-Phe-NH_2)171％,Fmoc-四肽(Fmco-Trp-Met-Asp-Phe-NH_2)32.88％,Fmoc-三肽·(Fmoc-Met-Asp-Phe-NH_2)0.17％,五肽·TFA(β-Ala-Trp-Met-Asp-Phe-NH_2·TFA)17.45％,四肽·TFA(Trp-Met-Asp-phe-NH_2·TFA)5.58％。 实验结果显示四肽胃泌素类似物的活性这比三肽的高,表明胃泌素C-端片段中色氨酸残基对泌酸活性十分重要。在胃泌素类似物的N-端导入保护基同样提高它们的生物学活性,而Fmoc-保护基的作用还强于Boc-保护性。推测其主要原因是在N-式加上一个疏水性强的基团后有利于形成一个与受体相结合的活性构象。     

胃泌素C-端四肽的N-乙酰化和糖化及其对泌酸活性的影响

本文报道了胃泌素C—端四肽N—乙酰化和糖化的方法,并用大白鼠胃灌流技术研究了它们对泌酸活性的影响。结果表明,乙酰化和糖化均可提高其泌酸活性,其中葡萄糖—1—脱氧果糖四肽(Glc—1—deoxyfru—Trp—Met—Asp—Phe—NH_2)的泌酸活性超过了商品五肽胃泌素(Boc—α—Ala—Trp—Met—Asp—Phe—NH_2)     

核盘菌AROM蛋白的三级结构分析

核盘菌编码AROM蛋白的arom基因已经被克隆测序,本文根据该基因翻译的氨基酸序列用同源模建方法和从头模建方法分析了AROM蛋白各结构域的三级结构和功能位点,以及该蛋白二聚体可能的组装方式。结果表明,核盘菌AROM蛋白的脱氢奎尼酸合酶结构域进一步由N-端含有一个Rossmann折叠的α/β结构域和C-端的α螺旋结构域组成;5-烯醇丙酮酰莽草酸-3-磷酸合酶结构域则由两个相似结构域组成,每个结构域含有不同拷贝数的β折叠和α螺旋;莽草酸激酶结构域的N-端由三个β折叠组成;脱氢奎尼酸酶结构域为(α2β2)3多肽,在N-端有一对反平行的β链,在C-端有loop环;莽草酸脱氢酶结构域含有一个由α/β组成的催化结构域和一个含有Rossmann折叠的NADPH结合结构域。     

促胰液素和生长抑素经血管灌流大鼠离体胃抑制胃酸分泌

本工作利用血管灌流离体大鼠胃研究促胰液素和生长抑素对泌酸的影响及其与内源性前列腺素E(PGE)和前列环素(PGI_2)释放的关系。结果表明:(1)促胰液素和生长抑素都能有效地抑制五肽胃泌素(G_5)促进胃酸分泌的作用,消炎病可翻转这种抑制作用。(2)促胰液素能显著促进PGE和PGI_2代谢产物6-酮-前列腺素F_(1α)(6-Keto-PGF_(1α))释放;生长抑素只能促进FGE释放。消炎痛分别阻断促胰液素对PGE和6-keto-PGF_(1α)释放及生长抑素对PGE释放的促进作用。上述结果提示:(1)促胰液素的抑酸效应由促进PGI_2和PGE释放介导;(2)生长抑素的抑酸效应通过促进PGE释放介导。     

胰岛素B链中肽段的合成 Ⅵ.N-端八肽衍生物的合成

胰岛素B链N-端八肽衍生物,卽cb·phe·val·asp(NH_2)·glu(NH_2)·(im-Bz)his·leu·(S-Bz)cys·gly·OC_2H_5,曾用cbz·(im-Bz)his·leu·OH与H·(S-Bz)cys·gly·OC_2H_5借DCCI缩合生成cbz·(im-Bz)his·leu·(S-Bz)cys·gly·OC_2H_5,然后经溴化氢的冰醋酸溶液脱去苄氧羰基后,依次与cbz·glu(NH_2)·ONP,cbz·asp(NH_2)·ONP,cbz·val·ONP和cbz·phe·ONP缩合生成。此外,该八肽衍生物还曾用cbz·phe·val·ONP和B_(3—8b)缩合或cbz·phe·val·asp(NH_2)·N_3和B_(4-8b)缩合生成。所得八肽经溴化氢的冰醋酸溶液脱去苄氧羰基后,能为氨肽酶完全消化。     

胰岛素B链中肽段的合成——Ⅲ.苄氧羰·苯丙·缬·门酰胺·谷酰胺·(Im-苄基)组氨酸苄酯的合成

胰島素B鏈中N-端五肽的衍生物,即N-Cbz·phe·val·asp(NH_2)·glu(NH_2)·(Im-Bz)his·OBz,曾依活化酯法从H·(Im-Bz)his·OBz开始,用N~α-Cbz·glu(NH_2)·ONP,N~α-Cbz·asp(NH_2)·ONP,及N-Cbz·phe·val·ONP依次向N-端引伸而得。此外,該五肽还依(2 3)的方案用DCCI法合成。用N~α-Cbz·phe·val·OH来合成活化酯时有消旋現象产生,但用(1 1)的方案可得光学純的二肽活化酯。从保护的五肽酯(B_(1-5))經較长时期的溴化氫醋酸溶液处理或催化氫化所得的(Im-Bz)-保护的自由五肽能为氨肽酶完全消化。     

黑曲霉β-葡萄糖苷酶的催化性质

通过测定黑曲霉β-葡萄糖苷酶的底物特异性,表明该酶不仅能水解纤维二糖和对硝基苯-β-D葡萄糖苷,还能微弱地水解对硝基苯-β-D-半乳糖苷和β-D-木糖苷。Ag~+、Cu~(2+)和Hg~(2+)对该酶有较强的抑制作用。该酶水解对硝基苯-β-D-葡萄糖苷、水杨苷和纤维二糖的Km值分别为2.32、19.11和30.18mmol/L,V_(max)则分别为412、237和198μmol·min~(-1)·mg~(-1),Lineweaver-Burk作图法表明,D-葡萄糖和δ-葡萄糖酸内酯对该酶显示竞争性抑制作用,其Ki分别为5.17和1.31mmol/L。     

GTPγs对柴胡皂甙(I)刺激胰腺腺泡酶分泌的影响

为了解柴胡皂甙(I)[SA(I)]刺激大鼠胰腺腺泡酶分泌的信号传导通路,研究了GTPγs对SA(I)剌激通透腺泡细胞酶分泌的影响.用SLO通透细胞的同时,加入GTPγs在15min期间能诱发酶分泌,10'mol·L-1GTPγs有最大促泌效应.GTPγs浓度依赖性的增强SA(I)促酶分泌作用,l0-7 mol·L-1 GTPγs导致10-5mol·L-1 SA(I)刺激酶分泌量增加到1.6倍.用SLO预通透腺泡10min后,加入GTPγs使SA(I)刺激酶分泌的量-效曲线左移,SA(I)的EC50从2 0×10-5mol·L-1减小到1 0×10-5mol·L-1.以上结果提示,SA(I)活化受体偶联的G蛋白包括在其刺激酶分泌的信号传导通路中.     

氮磷添加对杉木林土壤碳氮矿化速率及酶动力学特征的影响

以江西杉木林红壤为研究对象,开展野外长期氮(N)、磷(P)添加控制试验,设置对照(CK)、N(50kg N hm~(-2)a~(-1))、P(50kg P hm~(-2)a~(-1))、NP(50kg N hm~(-2)a~(-1)+50kg P hm~(-2)a~(-1))处理,分析N、P添加对土壤碳矿化速率(C_(min))、氮矿化速率(N_(min))和相关的β-1,4-葡萄糖苷酶(βG)和β-1,4-N-乙酰葡糖氨糖苷酶(NAG)动力学参数的影响。结果表明:(1)N添加明显降低了C_(min)和N_(min),比CK分别减少了25%和18%;N添加减小了NAG的潜在最大酶活性(V_(max))、半饱和常数(K_m)、催化效率(V_(max)/K_m),但差异不显著(P0.05);N添加显著增加了βG的V_(max)、K_m,但对V_(max)/K_m有抑制作用。(2)P输入(P、NP)较CK使NAG的V_(max)、K_m减小26%—60%;NP同时添加明显提高βG和NAG的V_(max)/K_m(P0.05),但P输入(P、NP)对C_(min)和N_(min)影响不显著(P0.05)。(3)C_(min)与土壤溶解性有机碳正相关,N_(min)与pH显著正相关,与土壤NH_4~+-N、NO_3~--N显著负相关;βG和NAG的V_(max)/K_m均与NH_4~+-N、NO_3~--N负相关(P0.05),K_m均与NH_4~+-N、NO_3~--N正相关(P0.05)。βG的V_(max)与NH_4~+-N、NO_3~--N正相关(P0.05),NAG的V_(max)与有机碳、全氮、全磷、有效磷负相关(P0.05)。研究结果表明,在亚热带杉木人工林中,N添加降低土壤pH,增加土壤有效氮含量,抑制βG和NAG的V_(max)/K_m,对土壤C_(min)和N_(min)产生抑制作用;而NP添加增加土壤有效磷含量,增加土壤βG和NAG的V_(max)/K_m。     

Catabolism of rat growth hormone-releasing factor(1-29) amide in rat serum and liver.

Clinical and veterinary uses of growth hormone-releasing factor [GRF(1- 29)NH2] require the design of analogs that are resistant to proteolysis by serum and liver degrading enzymes. This study investigated rat GRF(1-29)NH2 processing in serum and liver homogenate by means of high pressure liquid chromatography (HPLC). Synthetic rGRF(1-29)NH2 (30 microM) was incubated (0-120 min, 37 degrees C) in serum (49 +/- 8 mg prot./ml). The rGRF(1-29)NH2 (10 microM) was also incubated (0-120 min, 37 degrees C) with liver homogenate (200 +/- 6 micrograms prot./ml). Time course studies of rGRF(1-29)NH2 disappearance showed apparent half-lives of 18 +/- 4 min and 13 +/- 3 min in serum and liver homogenate, respectively. This was accompanied by the appearance of degradation products that were all less hydrophobic than the native peptide. In the serum, two major metabolites were detected and isolated by preparative HPLC. Combined results of amino acid analysis, sequencing, and chromatography with synthetic homologs revealed the presence of rGRF(1-20)OH and (3-20)OH. A small amount of rGRF(12-29)NH2, coeluting with rGRF(3-20)OH, was also found by sequencing. In the liver, rGRF(1-18)OH, (3-18)OH, and (1-10)OH were identified. The peptide bond Ala2-Asp3 (DPP IV cleavage site) was hydrolyzed in both serum and liver. Other tissue-specific cleavage sites were Arg11-Arg12 and Arg20-Lys21 (trypsin-like cleavage site) in the serum, and Tyr10-Arg11 and Tyr18-Ala19 (chymotrypsin-like cleavage site) in the liver.(ABSTRACT TRUNCATED AT 250 WORDS)     

Structural comparison of bovine erythrocyte, brain, and liver NADH-cytochrome b5 reductase by HPLC mapping

NADH-cytochrome b5 reductases purified from bovine erythrocytes and from bovine brain and liver microsomes solubilized with lysosomal protease were subjected to structural analysis by using HPLC mapping, amino acid analysis of the resulting peptides, and NH2-terminal sequence analysis of apoproteins. HPLC maps of the tryptic peptides derived from these enzymes were very similar to each other, and amino acid analysis of the HPLC-separated peptides indicated that the structures of these enzymes are identical except for the NH2-terminal region. The NH2-terminal sequence of the brain enzyme determined by automated Edman degradation was as follows: NH2-Phe-Gln-Arg-Ser-Thr-Pro-Ala-Ile-Thr-Leu-Glu-Asn-Pro-Asp- Ile-Lys-Tyr-Pro-Leu-Arg-Leu-Ile-Asp-Lys-Glu-Val-Ile- This sequence is identical to that of liver enzyme except that the liver enzyme started at the 3rd Arg or 4th Ser. The NH2-terminal amino acid residue of the soluble erythrocyte enzyme was not detected by automated Edman degradation. The sequence analysis of a tryptic peptide from the erythrocyte enzyme indicated that Leu is present before the NH2-terminal Phe of the brain enzyme. The recently reported sequence of the apparently identical protein (Ozols et al. (1985) J. Biol. Chem. 260, 11953-11961) differs in two amino acid assignments from our sequence.     

Primary structure of a 15-kDa protein from rat intestinal epithelium. Sequence similarity to fatty-acid-binding proteins

An abundant and novel cytosolic protein was purified from the rat intestinal epithelium by gel filtration, ion-exchange and hydroxylapatite chromatography. The protein was eluted into two different positions (fractions 1 and 2) on DEAE-cellulose chromatography. We have completed the primary structure of the protein of fraction 1 by Edman degradation. The protein (144565 Da) contains 127 amino acid residues and has an acetylated alanine at its NH2-terminus. Comparison of the primary structure of the protein with porcine gastrotropin [Walz, A. D., Wider, M. D., Snow, J. W., Dass, C. & Desiderio, D. M. (1988) J. Biol. Chem. 263, 14189-14195] and rat hepatic fatty-acid-binding protein revealed that identical residues within these proteins are found in 90 and 54 out of a total of 127 positions, respectively. Bioactivity studies demonstrated that neither the protein nor liver and intestinal fatty-acid-binding proteins influence gastric acid secretory activity in rats with gastric fistulas compared to pentagastrin. The protein showed very low affinity for palmitic-acid-binding in vitro assay system and only trace amounts of endogenous fatty acids were detected from the protein. The protein, rat intestinal 15-kDa protein is considered to be a new member of the fatty-acid-binding protein family based on its structural features.     

Chronic treatment with a stable obestatin analog significantly alters plasma triglyceride levels but fails to influence food intake; fluid intake; body weight; or body composition in rats

Obestatin (OB(1-23) is a 23 amino acid peptide encoded on the preproghrelin gene, originally reported to have metabolic actions related to food intake, gastric emptying and body weight. The biological instability of OB(1-23) has recently been highlighted by studies demonstrating its rapid enzymatic cleavage in a number of biological matrices. We assessed the stability of both OB(1-23) and an N-terminally PEGylated analog (PEG-OB(1-23)) before conducting chronic in vivo studies. Peptides were incubated in rat liver homogenate and degradation monitored by LC-MS. PEG-OB(1-23) was approximately 3-times more stable than OB(1-23). Following a 14 day infusion of Sprague-Dawley rats with 50 nmol/kg/day of OB(1-23) or a N-terminally PEGylated analog (PEG-OB(1-23)), we found no changes in food/fluid intake, body weight and plasma glucose or cholesterol between groups. Furthermore, morphometric liver, muscle and white adipose tissue (WAT) weights and tissue triglyceride concentrations remained unaltered between groups. However, with stabilized PEG-OB(1-23) we observed a 40% reduction in plasma triglycerides. These findings indicate that PEG-OB(1-23) is an OB(1-23) analog with significantly enhanced stability and suggest that obestatin could play a role in modulating physiological lipid metabolism, although it does not appear to be involved in regulation of food/fluid intake, body weight or fat deposition.     

Modulation of antioxidant enzyme activities, platelet aggregation and serum prostaglandins in rats fed spray-dried milk containing n-3 fatty acid

Spray-dried milk enriched with n-3 fatty acids from linseed oil (LSO) or fish oil (FO) were fed to rats to study its influence on liver lipid peroxides, hepatic antioxidant enzyme activities, serum prostaglandins and platelet aggregation. Significant level of α linolenic acid, eicosapentaenoic acid and docosahexaenoic acid were accumulated at the expense of arachidonic acid in the liver of rats fed n-3 fatty acid enriched formulation. The linseed oil and fish oil enriched formulation fed group had 44 and 112% higher level of lipid peroxides in liver homogenate compared to control rats fed groundnut oil enriched formulation. Catalase activity in liver homogenate was increased by 37 and 183% respectively in linseed oil and fish oil formulation fed rats. The glutathione peroxidase activity decreased to an extent of 25–36% and glutathione transferase activity increased to an extent of 34–39% in rats fed n-3 fatty acids enriched formulation. Feeding n-3 fatty acid enriched formulation significantly elevated the n-3 fatty acids in platelets and increased the lipid peroxide level to an extent of 4.2 to 4.5-fold compared to control. The serum thromboxane B₂ level was decreased by 35 and 42% respectively in linseed oil and fish oil enriched formulation fed rats, whereas 6-keto-prostaglandin F1α level was decreased by 17 and 23% respectively in linseed oil and fish oil enriched formulation fed rats. The extent and rate of platelet aggregation was decreased significantly in n-3 fatty acids enriched formulation fed rats. This indicated that n-3 fatty acids enriched formulation beneficially reduces platelet aggregation and also enhances the activities of hepatic antioxidant enzymes such as catalase and glutathione transferase.     

Effect of bacitracin on the biodegradation of β-endorphin

β-endorphin was incubated with rat brain homogenate, and the amino acids released were measured by amino acid analysis. Phe, Leu, Tyr, and Lys were liberated in the greatest amount indicating that the cleavage of Leu⁷⁷-Phe⁷⁸ and some Lys-X peptide bonds with endopeptidases followed by the removal of the terminal residues by exopeptidases are the main routes of β-endorphin degradation in the brain. Bacitracin considerably reduced the amino acid release from β-endorphin incubated with rat brain homogenate, and its action is suggested to be due to the inhibition of brain amino- and carboxypeptidases. Bacitracin also potentiated and prolonged the $\text{in vivo}$ analgesic activity of β-endorphin.     

Protective effect of aescin from the seeds of Aesculus hippocastanum on liver injury induced by endotoxin in mice

To investigate the effect and underlying mechanism of aescin on acute liver injury induced by endotoxin, liver injury was established by injecting lipopolysaccharide (LPS) in mice. Animals were assigned to seven groups: the control group and groups treated with LPS (40 mg/kg), aescin (3.6 mg/kg), LPS plus dexamethasone (4 mg/kg) and LPS plus aescin (0.9, 1.8 or 3.6 mg/kg). Hepatic histopathological changes were examined under a light microscope. Activities of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in serum were determined. Levels of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), nitric oxide (NO) and antioxidative parameters in liver homogenate were measured. Glucocorticoid receptor (GR), 11 beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) and 11 beta-hydroxysteroid dehydrogenase type 2 (11β-HSD2) expressions in liver were determined by western blotting. Treatment with escin could inhibit immigration of inflammatory cells, alleviate the degree of necrosis, and decrease serum ALT and AST activities. Aescin also down-regulated levels of inflammation mediators (TNF-α, IL-1β and NO) and 11β-HSD2 expression in liver, up-regulated GR expression, enhanced endogenous antioxidative capacity, but have no obvious effect on 11β-HSD1 expression in liver. The findings suggest aescin has protective effects on endotoxin-induced liver injury, and the underlying mechanisms were associated with its anti-inflammatory effects, up-regulating GR expression, down-regulating 11β-HSD2 experssion, and antixoidation.     

A unique enzyme catalyzing the formation of 4-hydroxyaniline from 4-amino-benzoic acid in Agaricus bisporus

A unique enzyme that catalyzes the formation of 4-hydroxyaniline from 4-aminobenzoic acid was found in the homogenate of Agaricus bisporus. The enzyme was prepared from the homogenate by (NH4)2SO4 fractionation, gel filtration and ion-exchange chromatography. The products formed from 4-aminobenzoic acid by the enzyme were shown to be 4-hydroxyaniline and CO2. The reaction required FAD, NAD(P)H and O2. These results indicate that the enzyme is a new FAD-dependent monooxygenase.     

The effects of low temperature and chloroquine on 125I-insulin degradation by the perfused rat liver

Low temperature and the lysosomotropic agent, chloroquine, were used to study the degradation of ¹²⁵I-insulin in a perfused rat liver. Insulin (1.5 × 10^?9m) was removed from the perfusate at 35 °C with a $\text{T}{}_{\mathrm{<mtext>1</mtext><mtext>2</mtext>}}$ of 12 min, and this process was slowed to 35 min at a temperature of 17 °C. Essentially no degradation of ¹²⁵I-insulin took place in the liver at 17 °C. After 90 min at that temperature 64% of the liver radioactivity had accumulated in the microsomal fraction of the tissue homogenate, while at 35 °C 60% of the radioactive material was in the supernatant fraction. Greater than 80% of the supernatant radioactivity was acid soluble. Rapid warming of a 17 °C-treated liver to 35 °C allowed the accumulated ¹²⁵I-insulin in the microsomal fraction to be degraded to acid-soluble products in the normal manner. Chloroquine (0.2 mm) also caused the liver to degrade insulin more slowly. At 60 min after adding ¹²⁵I-insulin to the chloroquine-treated liver, 50% of the radioactivity in the tissue was still present in the lysosome-rich fraction of the homogenate, while less than 10% was in this fraction in a control liver. The effects of low temperature show transfer of insulin to its degradative site is rate limiting for hormone catabolism and the inhibition by chloroquine suggests lysosomes have a role in insulin degradation by the liver.